Abstract:OBJECTIVE:To clarify the role of RhoC in the growth of hepatocellular carcinoma cells and its molecular mechanism, so as to explore the molecular target of tumor cell growth.METHODS:siRNA-RhoC plasmid was constructed and RhoC gene silencing the cell-line of hepatocellular carcinoma was setup. Cell growth was assessed by MTT assay. AgNORs staining was applied to determine cell proliferation. Plate cell clone test was conducted to examine the capacity of cell clone formation. FACS was adopted to measure the course of cell cycle and semi-quantitative RT-PCR was used to determine the expression of cell cycle proteins. In order to further determine the effect of RhoC expression on cell growth, a RhoC over-expression human hepatocellular cell line was setup by PcDNA3-RhoC plasmid transfection.RESULTS:The inhibition rate of RhoC was 82.3%. From the fourth day of cell culture, the growth of cells in RNAi group was significantly slower than that in parental Bel7402 and negative control groups (0.41 ± 0.10 vs. 0.73 ± 0.11 and 0.71 ± 0.07 respectively, P < 0.05). AgNORs staining showed that average cell stained particles in RNAi group was significantly lower than that in parental Bel7402 and negative control(1.23 ± 0.35 vs. 3.47 ± 0.93 and 3.17 ± 0.78, P < 0.01). Plate clone formation test showed that clone formation efficiency in the RNAi group was notably lower than that in the control group [(20.33 ± 5.42)% vs. (70.58 ± 10.10)% and (69.83 ± 14.77)%, respectively, P < 0.01]. Cell cycle analysis by FACS showed that G(0)/G(1) cell percentage in the RNAi group was significantly higher than that in the control group [(73.14 ± 5.93)% vs. (57.05 ± 5.97)% and (52.99 ± 4.80)%, P < 0.05]. Compared with Bel7402 and negative control groups, the expression of following growth associated genes was significantly decreased: cyclin D1(0.45 ± 0.21 vs. 1.25 ± 0.24 and 1.12 ± 0.15, respectively, P < 0.05)and CDK4 (0.55 ± 0.08 vs. 1.18 ± 0.32 and 1.10 ± 0.29, respectively, P < 0.05); the following genes were notably increased: p16(1.07 ± 0.23 vs. 0.36 ± 0.12 and 0.35 ± 0.13, respectively, P < 0.01)and p21(0.42 ± 0.12 vs. 0.17 ± 0.06 and 0.19 ± 0.08, respectively, P < 0.05). RhoC was highly expressed in PcDNA3-RhoC transfected hepatocellular cell line. From the third day on of the cell culture, cell growth in PcDNA3-RhoC group was remarkably higher than that in the HL7702 and PcDNA3 groups (0.83 ± 0.10 vs. 0.54 ± 0.11 and 0.58 ± 0.55, respectively, P < 0.05).CONCLUSIONS:RhoC is the key molecule in promoting hepatocellular cell growth, and is a promising target for tumor cell growth controlling.

Significance of Rac1 in the Proliferation and Transference of Hepatoma Cell

Role of RhoC-siRNA Expression Vector on Growth Velocity and Invasiveness of Hepatoma Carcinoma Cells

Construction of RhoC-siRNA expression vector and its role in invasion and metastasis ability of hepatoma carcinoma cell

Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells.

Effect of the Activity of Rac1 Gene Restrained in HCC on Its Proliferation and Invasive Ability

Lentivirus-mediated RhoT 1 down-expression inhibits pancreatic cancer cells proliferation , migration and invasion , and induces apoptosis

The Effect of Rac1 Sirna on the Biological Behaviors of Gastrointestinal Cancer Cells

Endothelial Rac1 is Essential for Hematogenous Metastasis to the Lung.

Effects of RhoA Gene Silencing on the Potentiality of Hepatocellular Carcinoma Cell Metastasis

Effect of RhoC on Hepatocellular Carcinoma Cell Growth and Related Molecular Mechanisms

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

[The Affect of Si-Rac1b on the Malignant Biological Behaviors of Colorectal Cancer Cell].

The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy

RhoC Overexpression-Induced Migration and Invasion of Human Normal Hepatocytes

Overexpression Of Rac1 In Leukemia Patients And Its Role In Leukemia Cell Migration And Growth

Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells Via Targeting RhoC in Vitro and in Vivo.

The NKD1/Rac1 feedback loop regulates the invasion and migration ability of hepatocarcinoma cells

Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma

The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells

Rac1, A Potential Target for Tumor Therapy

Effect of RhoA gene silencing on proliferation and migration of HepG2 cells